Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases
Abstract We have recently described Pz-1, a benzimidazole-based type-2 RET and VEGFR2 inhibitor. Based on a kinome scan, here we show that Pz-1 is also a potent (IC50 < 1 nM) TRKA/B/C inhibitor. Pz-1 potently inhibited proliferation of human cancer cells carrying either RET- or TRKA oncoproteins...
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/eab71864d5a542ee8748ff9464f7f61c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!